Astragalus membranaceus root

Incorporating Astragalus in Palliative Care

,

This Chinese herb, also known as Huang Qi or Astragalus membranaceus, has been used for centuries to support the immune system, restore Qi, and invigorate the spleen. (1) The dried root of astragalus is traditionally used, as compounds such as astragalus polysaccharide can be extracted from it. There are numerous pharmacological actions of astragalus polysaccharides, including regulating the immune system, anti-aging, antitumor effects, reducing blood sugar and lipids, antifibrotic, antibacterial, antiviral, radioprotective, and neuroprotective. (1,2) Traditional indications include weakened individuals with night sweats, frequent infectious illnesses, lack of vitality, poor digestion, and poor nutritional status. (3) Due to its multitude of physiological actions that have a widespread benefit throughout the body, Astragalus is often useful in the palliative care patient, where it has been found to benefit numerous issues. (4-10)

Cancer-related side-effects where Astragalus may be of benefit (4-10):

  • Neutropenia 
  • Anemia
  • Thrombocytopenia 
  • Anorexia 
  • Fatigue

The injectable form of astragalus called PG2, has numerous studies demonstrating its benefit in cancer-related fatigue. (11) A double-blind, multi-center, randomized study in 2019 found a 10% improvement in fatigue (using the Karnofsky Performance Status) in 65% of patients after only one treatment. (12) With the positive evidence, PG2 injection is now a part of the standard of care in Taiwan for cancer-related fatigue. (13)

A retrospective study published in 2021 found that patients with metastatic lung cancer being treated with immune checkpoint inhibitors who used injectable astragalus polysaccharide had an improvement in their neutrophil-to-lymphocyte ratio (NLR). (14)

The mechanisms of how astragalus exerts its benefits are multi-factorial, including its role in modulating the immune system, cytokines, and, therefore, the tumor microenvironment. For example, astragalus has been shown to facilitate the maturation of dendritic cells, leading to production of IL-12, shift Th2 towards Th1, and active T cells and NK cells, which subsequently leads to downstream changes in many cytokines.  (15, 16) It is assumed that these changes in cytokine expression, especially inflammatory cytokines, may be way astragalus induces an improvement in quality of life. (17)  These benefits to the immune system from astragalus have also led to investigations on its use in COVID-19 and various neurodegenerative diseases. (18, 19) Lastly, there have been studies demonstrating astragalus’ anticancer mechanisms, including inducing apoptosis in cancer cells, cell-cycle disruption, and inhibition of signal transduction. (15) 

For more information on astragalus and how it may be of benefit to your patients, consider the Advanced Integrative Oncology Palliative Care Course by the Integrative Oncology Institute.

References

  1. Zheng Y, Ren W, Zhang L, Zhang Y, Liu D, Liu Y. A Review of the Pharmacological Action of Astragalus Polysaccharide. Front Pharmacol. 2020;11:349. Published 2020 Mar 24. doi:10.3389/fphar.2020.00349
  2. Liu P, Zhao H, Luo Y. Anti-Aging Implications of Astragalus Membranaceus (Huangqi): A Well-Known Chinese Tonic. Aging Dis. 2017;8(6):868-886. Published 2017 Dec 1. doi:10.14336/AD.2017.0816
  3. Tilgner SM. Herbal Medicines: From the Heart of the Earth. 3rd ed. Wise Acres Publishing; 2020.
  4.  Wang SF, Wang Q, Jiao LJ, et al. Astragalus-containing Traditional Chinese Medicine, with and without prescription based on syndrome differentiation, combined with chemotherapy for advanced non-small-cell lung cancer: a systemic review and meta-analysis. Curr Oncol. 2016;23(3):e188. 
  5. Lv Y, Feng X, Zhu B. Study on effect of Astragalus membranaceus injection on hematopoiesis in anemic mice with myelosuppression]. Zhong Yao Cai. 2005;28(9):791-793. 
  6. He H, Zhou X, Wang Q, Zhao Y. Does the couse of astragalus-containing chinese herbal prescriptions and radiotherapy benefit to non-small-cell lung cancer treatment: a meta- analysis of randomized trials. Evid Based Complement Alternat Med. 2013;2013:426207. 
  7. Wang J, Yang Z, Long F, et al. Astragalus injection as an adjuvant treatment for colorectal cancer: a mata-analysis. Tradit Med Res. 2020;5(1):53-61. 
  8. Cao A, He H, Wang Q, Li L, An Y, Zhou X. Evidence of Astragalus injection combined platinum- based chemotherapy in advanced nonsmall cell lung cancer patients: A systematic review and meta-analysis. Medicine (Baltimore). 2019;98(11):e14798. 
  9. Lin S, An X, Guo Y, et al. Meta-Analysis of Astragalus-Containing Traditional Chinese Medicine Combined With Chemotherapy for Colorectal Cancer: Efficacy and Safety to Tumor Response. Front Oncol. 2019;9:749 
  10. Lee, J. J. & Lee, J. J. A phase II study of an herbal decoction that includes astragali radix for cancer- associated anorexia in patients with advanced cancer. Integr. Cancer Ther. 9, 24–31 (2010). 
  11. Chen HW, Lin IH, Chen YJ, et al. A novel infusible botanically-derived drug, PG2, for cancer-related fatigue: a phase II double-blind, randomized placebo-controlled study. Clin Invest Med. 2012;35(1):E1-E11. Published 2012 Feb 1. doi:10.25011/cim.v35i1.16100
  12. Wang CH, Lin CY, Chen JS, et al. Karnofsky Performance Status as A Predictive Factor for Cancer-Related Fatigue Treatment with Astragalus Polysaccharides (PG2) Injection-A Double Blind, Multi-Center, Randomized Phase IV Study. Cancers (Basel). 2019;11(2):128. Published 2019 Jan 22. doi:10.3390/cancers11020128
  13. Rau KM, Shun SC, Hung SH, et al. Management of cancer-related fatigue in Taiwan: an evidence-based consensus for screening, assessment and treatment. Jpn J Clin Oncol. 2023;53(1):46-56. doi:10.1093/jjco/hyac164
  14. Tsao SM, Wu TC, Chen J, Chang F, Tsao T. Astragalus Polysaccharide Injection (PG2) Normalizes the Neutrophil-to-Lymphocyte Ratio in Patients with Advanced Lung Cancer Receiving Immunotherapy. Integr Cancer Ther. 2021;20:1534735421995256. doi:10.1177/1534735421995256  
  15. He Z, Liu X, Qin S, et al. Anticancer Mechanism of Astragalus Polysaccharide and Its Application in Cancer Immunotherapy. Pharmaceuticals (Basel). 2024;17(5):636. Published 2024 May 15. doi:10.3390/ph17050636
  16. Xu Q, Cheng W, Wei J, Ou Y, Xiao X, Jia Y. Synergist for antitumor therapy: Astragalus polysaccharides acting on immune microenvironment. Discov Oncol. 2023;14(1):179. Published 2023 Sep 24. doi:10.1007/s12672-023-00798-w
  17. Huang WC, Kuo KT, Bamodu OA, et al. Astragalus polysaccharide (PG2) Ameliorates Cancer Symptom Clusters, as well as Improves Quality of Life in Patients with Metastatic Disease, through Modulation of the Inflammatory Cascade. Cancers (Basel). 2019;11(8):1054. Published 2019 Jul 25. doi:10.3390/cancers11081054
  18. Lee CY, Nguyen AT, Doan LH, et al. Repurposing Astragalus Polysaccharide PG2 for Inhibiting ACE2 and SARS-CoV-2 Spike Syncytial Formation and Anti-Inflammatory Effects. Viruses. 2023;15(3):641. Published 2023 Feb 27. doi:10.3390/v15030641
  19. Shi Y, Ma P. Pharmacological effects of Astragalus polysaccharides in treating neurodegenerative diseases. Front Pharmacol. 2024;15:1449101. Published 2024 Aug 2. doi:10.3389/fphar.2024.1449101
Scroll to Top